On Sept. 4, Hackensack Meridian Hackensack University Medical Center became the first hospital in the world to treat patients with Aquablation® therapy, using the new HYDROS™ Robotic System. The system treats men suffering from benign prostatic hyperplasia (BPH), which is more commonly known as an enlarged prostate.
The therapy is an innovative approach, delivering a heat-free waterjet that is so intense that it removes excess prostate issues. The new HYDROS System is delivered by an AI-powered robot that has been clinically proven to provide significant BPH symptom relief. In addition to providing relief, it also preserves sexual functions and continence across prostates of all shapes and sizes.
BPH is a common effect of aging, affecting half of all men aged between 51 and 60, with up to 99% reporting a decrease in their quality of life. BPH impairs urinary function, which makes it more difficult for people with the disease to urinate, as well as having a weak urinary stream.
“The symptoms of BPH are very annoying,” described Abdo Saad who was recently diagnosed with the condition and not satisfied with traditional treatment options including medications or surgery. “I did my research to find a more innovative alternative,” explained the 66-year-old computer engineer, who was once named ‘Innovator of the Year’ by his own industry. “I knew there had to be something more state-of-the-art, which I found at Hackensack University Medical Center.” Mr. Saad was able to find aid from Ravi Munver, MD, FACS, vice chair, Department of Urology and director of Minimally Invasive & Robotic Urologic Surgery at Hackensack University Medical Center.
The HYDROS Robotic System represents the next step in Aquablation therapy, featuring FirstAssist AI™ treatment planning, advanced image guidance and much more to ensure that it is providing the best care to patients.
“We are thrilled to be at the forefront of this groundbreaking treatment,” said Robert C. Garrett, CEO, Hackensack Meridian Health. “Enlarged prostate affects millions of men worldwide, and this new procedure offers them a new hope for improved quality of life.”
The addition of this system in the Hackensack Meridian Health system marks yet another groundbreaking move for the healthcare system in their move to provide the best possible care to all patients.
“We’re so proud Hackensack University Medical Center is the first hospital in the world to offer a revolutionary new treatment for enlarged prostate,” said Mark D. Sparta, FACHE, president, Northern Region, Hackensack Meridian Health. “This marks a significant milestone in men’s health.”